Cambridge Antibody Technology Group Limited company overview
Cambridge Antibody Technology Group Limited is a private limited company registered with company number 03234033. It was incorporated on 5 Aug 1996 and its current status is active.
The registered office is at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA. The company has 4 active officers. It was previously called Cambridge Antibody Technology Group PLC and 1 other name.
Cambridge Antibody Technology Group Limited upcoming deadlines
Year end accounts
Due 30 Sep 2027
Confirmation statement
Due 29 Aug 2027
Corporation tax payment
Due 1 Oct 2027
Dates are the ones Companies House holds for this company. Late accounts trigger automatic Companies House penalties starting at £150, and HMRC charges interest on late corporation tax.
Cambridge Antibody Technology Group Limited at a glance
30 years
Trading age
11,058 days since incorporation
4
Active officers
Iain, Matthew, Camilla, Hannah
491
Filings on record
Latest: 17 Aug 2026
100/100
Filing health score
Accounts and statement up to date
Directors of Cambridge Antibody Technology Group Limited
Former officers
23 more officers are on the register. See all on Companies House
Nature of business (SIC codes)
72190
Other research and experimental development on natural sciences and engineering
Allowable expenses for Cambridge Antibody Technology Group Limited
Based on Cambridge Antibody Technology Group Limited's SIC code (72190), these are typical tax-deductible expenses for a professional & creative services company. Claiming them lowers the profit you pay corporation tax on.
Design tools & equipment
Creative software, cameras, drawing tablets and props.
Professional memberships
HMRC-approved professional body subscriptions.
Business travel
Trains, flights, hotels and subsistence for client work.
Working from home
A share of household bills or the £6-a-week flat rate.
Vehicle & mileage
45p a mile for the first 10,000 business miles in a personal car.
Staff & director salaries
Wages, employer NI and pension contributions paid through PAYE.
Accountancy & legal fees
Bookkeeping, year-end accounts, tax advice and company secretarial costs.
Business insurance
Public liability, professional indemnity and employer's liability cover.
Phone & internet
Business mobile contracts, broadband and a share of home internet.
General guidance only — every expense must be wholly and exclusively for business. Ask an accountant
Tax guide for businesses like Cambridge Antibody Technology Group Limited
How much tax does a professional & creative services company pay?
UK companies pay corporation tax at 19% on profits up to £50,000, rising to 25% above £250,000, with marginal relief in between. Claiming every allowable expense reduces taxable profit.
Does a company like Cambridge Antibody Technology Group Limited need to register for VAT?
VAT registration is compulsory once taxable turnover passes £90,000 in any rolling 12 months. Many businesses register voluntarily to reclaim VAT on costs.
How much does an accountant cost for a limited company in Cambridge?
Fixed-fee accountants typically charge £60–£200 a month for a small limited company, covering year-end accounts, corporation tax and the confirmation statement.
Can directors of Cambridge Antibody Technology Group Limited pay themselves in dividends?
Most small company directors take a low salary plus dividends. Dividends are paid from profits after corporation tax, with an annual £500 dividend allowance.
Filing history
17 Aug 2026 · CS01
Confirmation statement made on 15 Aug 2026 with no updates
19 May 2026 · AA
Full accounts made up to 31 Dec 2025
19 Aug 2025 · CS01
Confirmation statement made on 15 Aug 2025 with no updates
2 Jun 2025 · AA
Full accounts made up to 31 Dec 2024
2 May 2025 · AP01
Appointment of Hannah Victoria Tattersall as a director on 1 May 2025
1 May 2025 · TM01
Termination of appointment of Adrian Charles Noel Kemp as a director on 1 May 2025
27 Nov 2024 · MA
Memorandum articles
27 Nov 2024 · RESOLUTIONS
Resolutions
20 Nov 2024 · CC04
Statement of companys objects
21 Aug 2024 · CS01
Confirmation statement made on 15 Aug 2024 with updates
28 May 2024 · AA
Full accounts made up to 31 Dec 2023
25 Oct 2023 · SH01
Allotment of shares on 28 Sep 2023
15 Aug 2023 · CS01
Confirmation statement made on 15 Aug 2023 with no updates
3 Jul 2023 · AA
Full accounts made up to 31 Dec 2022
26 Aug 2022 · CS01
Confirmation statement made on 15 Aug 2022 with no updates
16 Aug 2022 · CH01
Director's details changed for Matthew Shaun Bowden on 3 Aug 2022
4 Aug 2022 · AA
Full accounts made up to 31 Dec 2021
6 Dec 2021 · CH01
Director's details changed for Matthew Shaun Bowden on 6 Aug 2021
27 Aug 2021 · CS01
Confirmation statement made on 15 Aug 2021 with updates
6 Aug 2021 · AA
Full accounts made up to 31 Dec 2020
Showing the latest 20 of 491 filings. See the full history on Companies House
Accounting services for Cambridge Antibody Technology Group Limited
From tax to payroll, find accountants who look after every part of Cambridge Antibody Technology Group Limited’s finances.
Year-end accounts
Statutory accounts prepared and filed with Companies House on time, every year.
Corporation tax
CT600 returns filed with HMRC and tax planned so you only pay what you owe.
Payroll
Pay your team on time every month, with RTI submissions and pensions handled.
VAT & bookkeeping
Keep your books tidy and your VAT returns MTD-ready all year round.
Confirmation statement
Your annual confirmation statement checked and filed before the deadline.
Management accounts
Monthly or quarterly reports so you can see how the business is really doing.
More about Cambridge Antibody Technology Group Limited
About Cambridge Antibody Technology Group Limited
Cambridge Antibody Technology Group Limited is a UK private limited company based in Cambridge, registered at Companies House as company number 03234033 since 5 Aug 1996. Its listed activities include other research and experimental development on natural sciences and engineering. This page brings together its public record — directors, registered office, nature of business and filing history — in one easy place.
Cambridge Antibody Technology Group Limited filings and compliance
Every UK limited company must file annual accounts, a confirmation statement and a corporation tax return each year. Cambridge Antibody Technology Group Limited has 491 filings on record. Keeping on top of these deadlines avoids automatic penalties from Companies House and HMRC, which start at £150 for late accounts.
Looking for an accountant in Cambridge?
Businesses like Cambridge Antibody Technology Group Limited often use a local accountant for year-end accounts, corporation tax, VAT and payroll. Compare fixed-fee, regulated accountants near Cambridge and get free quotes in minutes.
This page shows public information from Companies House. Director of Cambridge Antibody Technology Group Limited?
Cambridge Antibody Technology Group Limited – frequently asked questions
What is the company number of Cambridge Antibody Technology Group Limited?
Cambridge Antibody Technology Group Limited is registered at Companies House under company number 03234033.
When was Cambridge Antibody Technology Group Limited incorporated?
Cambridge Antibody Technology Group Limited was incorporated on 5 Aug 1996 as a private limited company.
Who are the directors of Cambridge Antibody Technology Group Limited?
Current officers are Iain Alistair Collins (director), Matthew Shaun Bowden (director), Camilla Jane Johnstone (secretary) and Hannah Victoria Tattersall (director).
What does Cambridge Antibody Technology Group Limited do?
The company's registered nature of business (SIC) is 72190 – Other research and experimental development on natural sciences and engineering.
Where is Cambridge Antibody Technology Group Limited registered?
The registered office address is 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA.
Is Cambridge Antibody Technology Group Limited still trading?
According to its latest Companies House record the company status is active. Its most recent filing was confirmation statement made on 15 Aug 2026 with no updates on 17 Aug 2026.